2024-1 Product Development Award - Targeted call RFP
Author
RIGHT Foundation
Date
2024-05-31 10:06
Views
833
The RIGHT foundation is pleased to announce new funding opportunities: Product Development Award (PDA) Targeted Calls (Monoclonal Antibodies (mAbs)/ Diagnostics for STIs) on top of the open call. The PDA General call will continue to accept proposals on a rolling basis, and the Targeted calls will seek proposals on two specified topics during a fixed period. Detailed information can be found in the Request for Proposal (RfP) documents attached below.
* Schedules are subject to changes, depending on the situation. Applicants in each step will be informed accordingly.
1) Dates are determined about four weeks from the notification. A specific date will be notified to invited applicants.
2) Interactive interview with the Selection Committee is included in this step.
• Overview of RfPs
| PDA General Call | PDA Targeted Call for mAbs | PDA Targeted Call for STI Diagnostics | |
|---|---|---|---|
| Description | PDA General call seeks proposals aimed at developing vaccines, therapeutics, biologics, or diagnostic platforms, including technology transfer of target intervention from or to a Korean partner to alleviate infectious diseases in the World Bank-defined low- and middle-income countries (LMICs). | PDA Targeted call for Monoclonal Antibodies seeks proposals to validate novel technologies to lower the costs of producing/manufacturing mAbs to prevent and/or treat one of the three diseases: severe respiratory syncytial virus (RSV) disease, severe malaria, or diseases with a pandemic potential or viral pathogens with pandemic potential. | PDA Targeted call for STI Diagnostics seeks proposals that will accelerate development of and access to point-of-care diagnostic tests for high priority sexually transmitted infections (STIs): gonorrhoeae, chlamydia, trichomoniasis and syphilis. |
| Submission deadline for application | Until December 31, 2024, KST (on a rolling basis) |
Until 10:00 AM, May 27, 2024, KST | |
| Co-funding | Not Applicable | Not Applicable | FIND (See details and conditions below) |
• Evaluation timeline for PDA Targeted Call (mAbs/ STI Diagnostics)
| ITA submission deadline | Notification of Full proposal invitation | Full proposal submission date1) | Technical evaluation of Full proposal by Panel of Experts | Technical evaluation by Selection committee2) | Funding decision by the Board of Directors | Grant Agreement negotiation notice |
|---|---|---|---|---|---|---|
| 10:00 AM, 27 May 2024, KST | Early June 2024 | Early July 2024 | July-August 2024 | By early September 2024 | October 2024 | End October 2024 |
* Schedules are subject to changes, depending on the situation. Applicants in each step will be informed accordingly.
1) Dates are determined about four weeks from the notification. A specific date will be notified to invited applicants.
2) Interactive interview with the Selection Committee is included in this step.